Dr Reddy's Q3 net profit falls 38 percent to Rs 303 crore
New Delhi: Dr Reddy's Laboratories posted a 38.51 percent decline in consolidated net profit at Rs 302.7 crore for the third quarter ended December 31.
The company had posted a net profit of Rs 492.3 crore during the same period of previous fiscal.
Its total revenue from operations stood at Rs 3,834.1 crore for the quarter under review. It was Rs 3,723.2 crore during the third quarter of 2016-17, Dr Reddy's Labs said in a regulatory filing.
The company said total revenue from operations for the quarter was not comparable consequent to the introduction of Goods and Services Tax on July 1.
"Revenue from operations for the earlier periods (before July 1) included excise duty which is now subsumed in GST," it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd